Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin.
Pinedo
Daryl M
DM
Southern Illinois University School of Medicine, Department of Internal Medicine, Springfield, IL, USA.
Shah-Khan
Farheen
F
Shah
Prabodh C
PC
D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000009:adverse effects*; D000077150:Oxaliplatin; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced* / Q000175:diagnosis
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin